PubMed

Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.

Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M.

Ann Intern Med. 2004 May 4;140(9):689-99.PMID: 15126252 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.

[No authors listed]

JAMA. 1998 Nov 25;280(20):1757-63. Erratum in: JAMA 1999 Jan 27;281(4):325. PMID: 9842951 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

CDC Diabetes Cost-effectiveness Group.

JAMA. 2002 May 15;287(19):2542-51.PMID: 12020335 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening for proteinuria in US adults: a cost-effectiveness analysis.

Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR.

JAMA. 2003 Dec 17;290(23):3101-14.PMID: 14679273 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

Hutton DW, Tan D, So SK, Brandeau ML.

Ann Intern Med. 2007 Oct 2;147(7):460-9.PMID: 17909207 [PubMed - indexed for MEDLINE]Related articlesFree article

Visual screening for malignant melanoma: a cost-effectiveness analysis.

Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA.

Arch Dermatol. 2007 Jan;143(1):21-8.PMID: 17224538 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.

Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S.

Ann Intern Med. 2005 Jul 19;143(2):89-99.PMID: 16027450 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.

Hu D, Hook EW 3rd, Goldie SJ.

Ann Intern Med. 2004 Oct 5;141(7):501-13. Erratum in: Ann Intern Med. 2004 Nov 2;141(9):744. PMID: 15466767 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

Vijan S, Hofer TP, Hayward RA.

JAMA. 2000 Feb 16;283(7):889-96.PMID: 10685713 [PubMed - indexed for MEDLINE]Related articlesFree article

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, Freedberg KA.

Ann Intern Med. 2006 Dec 5;145(11):797-806.PMID: 17146064 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of digital mammography breast cancer screening.

Tosteson AN, Stout NK, Fryback DG, Acharyya S, Herman BA, Hannah LG, Pisano ED; DMIST Investigators.

Ann Intern Med. 2008 Jan 1;148(1):1-10.PMID: 18166758 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of HIV screening in patients older than 55 years of age.

Sanders GD, Bayoumi AM, Holodniy M, Owens DK.

Ann Intern Med. 2008 Jun 17;148(12):889-903.PMID: 18559840 [PubMed - indexed for MEDLINE]Related articlesFree article

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia.

Blake GJ, Ridker PM, Kuntz KM.

Am J Med. 2003 Apr 15;114(6):485-94.PMID: 12727581 [PubMed - indexed for MEDLINE]Related articles

Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

Eddy DM, Schlessinger L, Kahn R.

Ann Intern Med. 2005 Aug 16;143(4):251-64.PMID: 16103469 [PubMed - indexed for MEDLINE]Related articlesFree article

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.PMID: 17999842 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost-effectiveness of screening for oral cancer in primary care.

Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, Augustovski F.

Health Technol Assess. 2006 Apr;10(14):1-144, iii-iv. Review.PMID: 16707071 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race.

Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG.

Ann Intern Med. 2003 Jun 17;138(12):960-8.PMID: 12809452 [PubMed - indexed for MEDLINE]Related articlesFree article

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.

Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA.

Nephrol Dial Transplant. 2008 Apr;23(4):1216-23.PMID: 18359872 [PubMed - indexed for MEDLINE]Related articles

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.

Hobbs FD, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, Raftery J, Davies M, Lip G.

Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74.PMID: 16202350 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group.

Ann Intern Med. 2005 Mar 1;142(5):323-32.PMID: 15738451 [PubMed - indexed for MEDLINE]Related articlesFree article